Promoter holding
64.27%
TT
Thyrocare Technologies Limited - Due diligence report
A 360° intelligence report on Thyrocare: trust score, financial health, credit view, compliance, directors, growth and distress signals - ge…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Thyrocare — 360° Intelligence Report
Generated from MCA filings & public records74/100
Trust Score
Moderate
Thyrocare is assessed as Moderate with a Trust Score of 74/100. Thyrocare is an active public limited indian non-government company incorporated in 2000, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 09 Jul 2026 from the latest processed filings. Thyrocare Technologies Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
68/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
30/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- No open charges - unencumbered balance sheet.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 2 satisfied (45.05 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 1 | 48.0 cr |
| Uti Bank Ltd; | 1 | 48.0 cr |
Compliance Score: 68/100 Moderate
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 2 court forum(s).
- 1 auditor resignation(s) filed - latest: BSR and Co on 2015-06-20.
- Delayed payments to MSME suppliers disclosed (4 disclosure(s)).
- 20 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 30/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ALOK KUMAR JAGNANI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NISHANT AMILAL SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| HARSHIL JITEN VORA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ANANDH SUNDAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| INDUMATI GOPINATHAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ALOK KUMAR JAGNANI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DHAVAL RAJESH SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAHUL FRANKLIN GUHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAHUL FRANKLIN GUHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DHARMIL NIRUPAM SHETH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BRIJESH KUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRAPTI ISHWAR GILADA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BRIJESH KUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Vikram Gupta | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 14 directors on the board.
- ALOK KUMAR JAGNANI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- 9 director exits in 3 years - high churn.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Docon Technologies Private Limited
Subsidiaries
1
Group entities
2
Capital events
7 allotment(s) · 3 transfer(s)
Promoters hold a minority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Nueclear Healthcare Limited | Subsidiary Company | 74.00% |
| Docon Technologies Private Limited | Holding Company | 74.00% |
| Pulse Hitech Health Services (ghatkopar) Llp | Subsidiary Company | 74.00% |
| Equinox Labs Private Limited | Associate Company | 74.00% |
Key managerial personnel: ALOK KUMAR JAGNANI (CFO) · RAHUL FRANKLIN GUHA (CEO) · RAHUL FRANKLIN GUHA (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 85 · Distress 70
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Net margin improved to 61%.
Operating for 26+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 38% in a year.
6 director exits within 2 years.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 4.10 Lakh.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence70/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment88/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
Investor view86/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 4 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events21 Aug 2025
Director appointed
Vikram Gupta (Cfo)
31 Jul 2025
Last AGM held
Annual general meeting
24 Jul 2025
Director appointed
ALOK KUMAR JAGNANI (Director)
Director ceased
ALOK KUMAR JAGNANI
31 Mar 2025
Latest balance sheet
Filed with ROC
13 Feb 2025
Director appointed
BRIJESH KUMAR (Company Secretary)
31 Jan 2025
Director appointed
BRIJESH KUMAR (Company Secretary)
Director ceased
RAMJEE DORAI
20 Sep 2024
Director ceased
NEETIN SHIVAJIRAO DESAI
22 Aug 2024
Director ceased
NISHANT AMILAL SHAH
Director ceased
ANANDH SUNDAR
20 Aug 2024
Director ceased
GOPAL SHIVRAM HEGDE
16 Jul 2024
Charge satisfied
Hdfc Bank Limited
15 Jun 2024
Director appointed
NISHANT AMILAL SHAH (Director)
Director appointed
ANANDH SUNDAR (Director)
10
Key Observations
Auto-generated from the data aboveRevenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
14 active director(s) / partner(s); review board churn before relying on management continuity.
20 active GST registration(s) indicate ongoing business operations.
All 2 registered charge(s) stand satisfied - past borrowings repaid.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 7 security allotment(s) - amounts available in the full report.
5 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Medinovaindia | L85110TG1993PLC015481 | Hyderabad, Telangana, India |
| Aspira | L85100MH1973PLC289209 | Mumbai, Maharashtra, India |
| P H Diagnostic Centre Private Limited | U85110PN1995PTC213675 | Pune City, Maharashtra, India |
| Neuberg Diagnostics | U85300TN2017PTC114099 | Saidapet, Tamil Nadu, India |
| Vijaya Diagnostic Centre | L85195TG2002PLC039075 | Hyderabad, Telangana, India |
| Medplus | L85110TG2006PLC051845 | Hyderabad, Telangana, India |
| Metropolis India | L73100MH2000PLC192798 | Mumbai, Maharashtra, India |
| Dr Lal Pathlabs | L74899DL1995PLC065388 | New Delhi, Delhi, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Thyrocare before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Thyrocare: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Thyrocare - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Thyrocare pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Thyrocare - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Thyrocare an active company?
Thyrocare has MCA status “Active” with a compliance score of 68/100 (Moderate).
Is Thyrocare financially healthy?
Thyrocare has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Thyrocare?
Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Thyrocare?
The ultimate holding entity is Docon Technologies Private Limited. 14 active director(s) are on record.
Does Thyrocare have loans or charges against its assets?
No open charges - all 2 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Thyrocare up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 68/100 (Moderate).
Is it risky to lend to Thyrocare?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
